Drug intelligence / Profile preview

NP 06-1

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

NP 06-1 is a dietary supplement formulated as a combination of two botanical extracts: *Phellodendron amurense* bark and *Citrus sinensis* peel, standardized to contain berberine (from Phellodendron) and polymethoxylated flavones (PMFs, from citrus). It has been evaluated in randomized, double-blind, placebo-controlled clinical trials for its effects on osteoarthritis of the knee and cardiovascular risk factors. Mechanistically, NP 06-1 exerts **anti-inflammatory actions** (partly via berberine, which inhibits inflammatory cytokines and mediators such as prostaglandin E2, IL-12, tumor necrosis factor-alpha, IL-6, CRP, and haptoglobin) and has been shown to improve metabolic parameters, including reducing triglycerides, LDL cholesterol, blood pressure, fasting glucose, and promoting weight loss. Its use has primarily targeted osteoarthritis and metabolic syndrome, with demonstrated safety over at least 8 weeks of use in adults[1][3][5].

Other names
NP06-1NP-06-1NP 06-1
02

Targets

IL-6 (Interleukin 6)IL12 (Interleukin-12)TNFA (Tumor necrosis factor alpha (soluble))PGE2 (Prostaglandin E2)

Beyond the preview

Go deeper on NP 06-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NP 06-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call